Evaluation of Lung Injury after Three-dimensional Conformal Stereotactic Radiation Therapy for Solitary Lung Tumors: CT Appearance

Radiology

Volumn 230, Issue 1, 2004, Pages 101-108

  Aoki, Tetsuya ^a   Nagata, Yasushi ^a   Negoro, Yoshiharu ^a   Takayama, Kenji ^a   Mizowaki, Takashi ^a   Kokubo, Masaki ^a   Oya, Natsuo ^a   Mitsumori, Michihide ^a   Hiraoka, Masahiro ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Lung neoplasms, CT; Lung neoplasms, therapeutic radiology; Radiations, injurious effects, complications of therapeutic radiology; Stereotaxis; Therapeutic radiology, three dimensional

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; HUMAN; LINEAR ACCELERATOR; LUNG INJURY; LUNG TUMOR; PRIORITY JOURNAL; RADIATION DOSE; SIMULATOR; STEREOTAXIC SURGERY; TREATMENT OUTCOME; TUMOR VOLUME;

FOLLOW-UP STUDIES; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; RADIOTHERAPY, CONFORMAL; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0347479227     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2301021226     Document Type: Article

References (25)

1. Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator: clinical experience of the first thirty-one patients. Acta Oncol 1995; 34:861-870.
2. Wulf J, Hadinger U, Oppitz U, Thiele W, Ness-Dourdoumas R, Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001; 177:645-655.
3. Takai Y, Mituya M, Nemoto K, et al. Simple method of stereotactic radiotherapy without stereotactic body frame for extracranial tumors. Nippon Igaku Hoshasen Gakkai Zasshi 2001; 61:403-407.
4. Nagata Y, Negoro Y, Aoki T, et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2002; 52:1041-1046.
5. Nakagawa K, Aoki Y, Tago M, Terahara A, Ohtomo K. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms. Int J Radiat Oncol Biol Phys 2000; 48:449-457.
6. Uematsu M, Shioda A, Suda A, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001; 51:666-670.
7. Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 1998; 82:1062-1070.
8. Negoro Y, Nagata Y, Aoki T, et al. The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: reduction of respiratory tumor movement and evaluation of the daily setup accuracy. Int J Radiat Oncol Biol Phys 2001; 50:889-898.
9. Ikezoe J, Takashima S, Morimoto S, et al. CT appearance of acute radiation-induced injury in the lung. AJR Am J Roentgenol 1988; 150:765-770.
10. Libshitz HI, Shuman LS. Radiation-induced pulmonary change: CT findings. J Comput Assist Tomogr 1984; 8:15-19.
11. Mah K, Poon PY, Van Dyk J, Keane T, Majesky IF, Rideout DF. Assessment of acute radiation-induced pulmonary changes using computed tomography. J Comput Assist Tomogr 1986; 10:736-743.
12. Mesurolle B, Qanadli SD, Merad M, et al. Unusual radiologic findings in the thorax after radiation therapy. RadioGraphics 2000; 20:67-81.
13. Pagani JJ, Libshitz HI. CT manifestations of radiation-induced change in chest tissue. J Comput Assist Tomogr 1982; 6:243-248.
14. Park KJ, Chung JY, Chun MS, Suh JH. Radiation-induced lung disease and the impact of radiation methods on imaging features. RadioGraphics 2000; 20:83-98.
15. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92:205-216.
16. Trotti A, Byhardt R, Stetz J, et al. Common toxicity criteria: version 2.0 an improved reference for grading the acute effects of cancer treatment-impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000; 47:13-47.
17. Inoue T, Kim EE, Komaki R, et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995; 36:788-793.
18. Patz EF Jr, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology 1994; 191:379-382.
19. Kubota K. From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology. Ann Nucl Med 2001; 15:471-486.
20. Seppenwoolde Y, Lebesque JV. Partial irradiation of the lung. Semin Radiat Oncol 2001; 11:247-258.
21. Libshitz HI, DuBrow RA, Loyer EM, Charnsangavej C. Radiation change in normal organs: an overview of body imaging. Eur Radiol 1996; 6:786-795.
22. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999; 45:323-329.
23. Graham MV. Predicting radiation response. Int J Radiat Oncol Biol Phys 1997; 39:561-562.
24. Skwarchuk MW, Jackson A, Zelefsky MJ, et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 2000; 47:103-113.
25. Jackson A, Skwarchuk MW, Zelefsky MJ, et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 2001; 49: 685-698.